Global Menopause Market is anticipated to grow at a CAGR of 7.10% by 2027 | DelveInsight Estimates

DelveInsight's Menopause Market Insights and Forecast report provides the current and forecast of Menopause, upcoming innovations, individual market shares of the products, challenges, drivers, and barriers, market trends, and key competitors in the Menopause Market scenario.

 

Some facts of the Menopause Market Report:

·         Global menopause market was valued at USD 15.53 billion in 2021, growing at a CAGR of 7.10% during the forecast period from 2022 to 2027 to reach USD 23.44 billion by 2027.

·         The demand for products that help in management of menopause symptoms is witnessing a surge majorly due to the rising female aging population wherein age plays a prominent role in regulating menstrual cycle and the growing awareness regarding menopause among people. Thereby boosting the growth of the menopause market during the forecast period from 2022-2027.

·         As per the figures quoted by the World Health Organization (WHO) in their Decade of Healthy Ageing (2020–2030) Report, the people in the age group of 60 years and above will account for a 34% higher share in the total population growing from one billion in 2019 to 1.4 billion in 2030.

·         For instance, as per the facts provided by the United Nations Fund for Population Activities (2021), it has been estimated that by 2050, the older population in the APAC region would reach to 1.3 billion, out of which 53% of the total population share would be accounted for by the females.

·         Some of the companies working in Menopause Market are ISIDEN, Novapharm, Arkopharma, Pileje, Thermamex, ÉLERTÉ Laboratories, Serelys Pharma, Besins Healthcare, Bayer, ITALFARMACO S.p.A, Pfizer Inc, Mylan NV, Teva Pharmaceuticals, TherapeuticsMD, Inc , Novo Nordisk, Novartis, Millicent Pharma, PADAGIS LLC, Vertical Pharmaceuticals LLC, Amgen and Others.

 

To know more facts about Menopause Market Research Report, Click Here: Menopause Market Assessment

View Report: https://www.delveinsight.com/report-store/menopause-market?utm_source=SatPR&utm_medium=pressrelease&utm_campaign=apr

 

Recent Developmental Activities in Menopause Market:

·         In September 2021, Theramex received the regualatory approval for Bijuva® / Bijuve® (1mg estradiol / 100mg progesterone) across Europe and the UK. It is the first, and only, body-identical hormone therapy treatment (HRT) for estrogen deficiency symptoms in post-menopausal women with intact uterus and to be administered orally.

·         In April 2019, Amgen and UCB (Euronext Brussels: UCB) received the regulatory approval from the U.S. Food and Drug Administration (FDA) for EVENITY™ (romosozumab-aqqg) which is intended for the treatment of osteoporosis in postmenopausal women at high risk for fracture.

 

Know more in detail about the recent developmental activities: Menopause Treatment Landscape

View Report: https://www.delveinsight.com/report-store/menopause-market?utm_source=SatPR&utm_medium=pressrelease&utm_campaign=apr

 

Menopause Companies:

ISIDEN, Novapharm, Arkopharma, Pileje, Thermamex, ÉLERTÉ Laboratories, Serelys Pharma, Besins Healthcare, Bayer, ITALFARMACO S.p.A, Pfizer Inc, Mylan NV, Teva Pharmaceuticals, TherapeuticsMD, Inc , Novo Nordisk, Novartis, Millicent Pharma, PADAGIS LLC, Vertical Pharmaceuticals LLC, Amgen

 

To get free access to Detailed information on Menopause Market Analysis, Click here: Menopause Companies and Product

 View Report: https://www.delveinsight.com/report-store/menopause-market?utm_source=SatPR&utm_medium=pressrelease&utm_campaign=apr

 

Scope of the Menopause Market Report

·         Study Period: 2019 - 2027

·         Base Year: 2021

·         Forecast Period: 2022 - 2027

·         By Treatment Type (Hormonal Products, Non-Hormonal Products, And Dietary Supplements)

·         By Distribution Channel (Hospitals, Retail, And Online Pharmacies)

·         By Geography (North America, Europe, Asia-Pacific, and Rest of the World).

·         Delveinsight Analysis: Global menopause market was valued at USD 15.53 billion in 2021, growing at a CAGR of 7.10% during the forecast period from 2022 to 2027 to reach USD 23.44 billion by 2027.

 

Get free Access to the Menopause Sample Pages, Click here: Menopause Sample Report

View Report: https://www.delveinsight.com/report-store/menopause-market?utm_source=SatPR&utm_medium=pressrelease&utm_campaign=apr

 

Table of Contents:

1. Menopause Market Report Introduction

2. Menopause Market Executive Summary

3. Regulatory Analysis

4. Menopause Market Key Factors Analysis

5. Menopause Market Porter’s Five Forces Analysis

6. COVID-19 Impact Analysis on Menopause Market

7. Menopause Market Layout

8. Menopause Market Global Company Share Analysis & Key 3-5 Companies

9. Menopause Market Company and Product Profiles

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us

 

View Report: https://www.delveinsight.com/report-store/menopause-market?utm_source=SatPR&utm_medium=pressrelease&utm_campaign=apr

 

Latest Report:

Pediatric Obesity Market | France Healthcare Outlook Report | Gastric Neuroendocrine Tumours Market | Italy Healthcare Outlook Report | Acanthamoeba Keratitis Market | Progressive Multifocal Leukoencephalopathy Market | Kernicterus Market | Contraceptive Drugs Market | Dental Implants and Prosthesis Market | Precocious Puberty Market | Menopause Market | Urinary Retention Market | Encephalitis Market | Exophthalmos Market | Premature Ejaculation Market | Endoscopes Market | Gout Market | Non-ST Segment Elevation Acute Coronary Syndromes (NSTE ACSs) Market | Chronic Progressive multiple sclerosis Market | Cough Assisted Device Market | Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) Market | Gastroparesis Market | Gouty Arthritis (Gout) Market | Graves Orbitopathy Market | Graves’ Disease Market | Head and Neck cancer (HNC) Market

 

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.  Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Media Contact

Company Name: DelveInsight Business Research LLP

Contact Person: Ankit Nigam

Email: info@delveinsight.com

Phone: +19193216187

City: Albany

State: New York

Country: United States

Website: https://www.delveinsight.com

 

 

  

Comments

Post a Comment

Popular posts from this blog

How Competitive intelligence is transforming the scenario for Biotech firms?

What is Competitive intelligence service? Competitive intelligence ideally means gathering information on rival business in the market, analyse the information and use the information to strategize to yield positive results. Going by the definition, competitive intelligence assembles actionable information from diverse published and unpublished sources, collected efficiently and ethically. So, analysts performing Competitive intelligence for their clienteles present a detailed picture of the marketplace, forthcoming challenges and the ways to face them, even before the can harm the client’s business. What could it mean? Competitive intelligence can often give a wrong idea, as it may misunderstood as a service which can help gain an advantage over the rivals. However, this is not the case. Competitive intelligence is an ethical and legal practise undertaken involving the study of analytical data, analysing the market and optimizing the relevant and realistic strategies t
Read more

Vernal Keratoconjunctivitis Market

(Albany, US) DelveInsight’s “ Vernal Keratoconjunctivitis Market  Insights, Epidemiology, and Market Forecast-2030 ” report provides an in-depth understanding of the disease, historical and forecasted epidemiology, as well as Vernal Keratoconjunctivitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Some of the key facts of the  Vernal Keratoconjunctivitis Market The increasing population and rising prevalence of Vernal Keratoconjunctivitis generates a large patient population in the global market. In 2017, a total of 4,752,356 patients were affected by Vernal Keratoconjunctivitis in the global market. China contributes the largest share among EU-5, and Japan, with 2,248,706 cases in 2017. The total diagnosed prevalent population of Vernal Keratoconjunctivitis was 2,943,057 in the global market.   Request for Sample Report: https://www.delveinsight.com/report-store/vernal-kerato
Read more

Hypothalamic Obesity Market by DelveInsight

  (New York, USA) DelveInsight’s “ Hypothalamic Obesity Market Insights, Epidemiology, and Market Forecast-2032 ” report delivers an in-depth understanding of Hypothalamic Obesity, historical and forecasted epidemiology as well as the Hypothalamic Obesity market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Hypothalamic Obesity market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Hypothalamic Obesity market size from 2019 to 2032, segmented by seven major markets. The Report also covers current Hypothalamic Obesity treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Hypothalamic Obesity market. Request for a Free Sample Report @  Hypothalamic Obesity Market Forecast Some facts of the Hypothalamic Obesity Market Report are: Accordi
Read more